|
| Title |
|
|
|
Mutation and methylation analysis of circulating tumor DNA can be used for follow-up of metastatic colorectal cancer patients
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
Clinical colorectal cancer | |
| Publication |
|
|
|
2018
| |
| ISSN |
|
|
|
1533-0028
| |
| Volume/pages |
|
|
|
17:2(2018), p. E369-E379
| |
| ISI |
|
|
|
000432978800022
| |
| Pubmed ID |
|
|
|
29605591
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (open access) |
|
|
| | |
| Full text (publisher's version - intranet only) |
|
|
| | |
|
| Faculty/Department |
|
|
|
| |
| Research group |
|
|
|
| Project info |
|
|
|
Molecular analysis of cell free circulating DNA (cfDNA) and/or circulating tumour cells (CTC) as 'liquid biopsy' for predictive biomarker assessment in patients with metastatic colorectal cancer (mCRC).
| Publication type |
|
|
| | | |
| Subject |
|
|
| | | |
| Affiliation |
|
|
|
Publications with a UAntwerp address
| |
|
|
|
| Identification |
|
| |
|
|
| Creation |
|
| |
12.06.2018
|
|
| Last edited |
|
| |
23.03.2020
|
|
| To cite this reference |
|
|
| | |
|
| |